Home› Stocks› CRL
Not investment advice. AI-generated analysis for educational purposes only. All trading involves risk of loss. Past performance does not guarantee future results. Full disclaimer

CRL

STRONG BUY

Health Care · S&P 500

Last updated: September 11, 2026 at 15:54 UTC

TRADEWISE AI SCORE

87

out of 100 — 6-factor composite

6-Factor Analysis

Based on Jegadeesh & Titman (1993) momentum and Barroso & Santa-Clara (2015) volatility targeting.

FactorValueStrengthDetail
Composite Momentum +57.1%
Multi-timeframe weighted (1/3/6/12mo)
Relative Strength vs SPY +43.2%
3-month outperformance vs S&P 500
20-Day Momentum +0.5%
Short-term price momentum
RSI-14 39.1
Relative Strength Index
Volatility 28.4%
20-day annualised: 28.4%

AI Debate Summary

4 AI agents (Research, Risk, Macro, Devil's Advocate) debated CRL.

AI Debate from September 11, 2026 — data may be outdated. Get fresh analysis
ATLAS BUY 72.0%

VOTE: BUY CONFIDENCE: 72 --- **ASSESSMENT: BULLISH** CRL presents a compelling setup in a TRENDING_BULL regime despite recent weakness and fundamental headwinds. The stock has been rejected repeated

Read full analysis →

SENTINEL HOLD 35.0%

VOTE: HOLD CONFIDENCE: 35 --- ## ASSESSMENT: BEARISH on Entry Timing CRL presents a **structural conflict between regime tailwinds and company-specific headwinds** that makes position sizing unusual

Read full analysis →

HORIZON HOLD 52.0%

VOTE: HOLD CONFIDENCE: 52 --- ## 1. MACRO-STOCK TRANSMISSION **Healthcare Diagnostics & Research in Current Macro Environment:** CRL operates in a counter-cyclical defensive sector (healthcare diag

Read full analysis →

CONTRARIAN HOLD 58.0%

VOTE: HOLD CONFIDENCE: 58 ADVERSARIAL CLEARANCE: PASS --- ## 1. STRONGEST BULL CASE CRL has generated a **+57.1% composite momentum signal** with 87/100 momentum score, is outperforming SPY by +43.2

Read full analysis →

CONSENSUS VETO_APPROVED — 54% agreement

Full debate reasoning available on Pro tier.

Market Regime Context

CURRENT REGIME CHOPPY (Day 7)

TradeWise monitors 5 market states (CALM → CRISIS) using VIX, breadth, and tail risk signals. In CHOPPY regime, the system adjusts position limits, trailing stops, and cash reserves automatically. Learn more about regime detection.

Get real-time AI alerts for CRL

4 AI agents debate every trade. 6-factor scoring. Regime-adaptive risk management. 14-day free trial, no credit card.

Start Free Trial →

Health Care Sector Peers

LLYUNHJNJABBVMRKTMOABTDHRPFEAMGN

View all Health Care stocks →

Compare

CRL vs LLYCRL vs UNHCRL vs JNJCRL vs ABBVCRL vs MRK

Frequently Asked Questions

Is CRL a buy right now?

Based on TradeWise's 6-factor AI model, CRL currently scores 87/100, indicating a STRONG BUY signal. This combines momentum, volume, trend structure, volatility, sector relative strength, and drawdown analysis. The current market regime is CHOPPY. Updated September 11, 2026 at 15:54 UTC.

What is the TradeWise AI score for CRL?

CRL has a TradeWise AI score of 87/100. Scores above 80 indicate STRONG BUY, 65-80 BUY, 45-65 HOLD, 30-45 WEAK, below 30 AVOID. Scores are updated daily based on the V56 momentum engine scanning all S&P 500 stocks.

How does CRL compare to LLY?

Compare CRL against sector peers using our head-to-head AI comparison tool. Each comparison shows 6-factor score breakdown, AI debate excerpts, and regime-adjusted analysis. See comparison →

Disclaimer: TradeWise provides AI-generated analysis for educational purposes only. This is not financial advice. Past performance does not guarantee future results. All investing involves risk of loss. Backtested results are hypothetical. Consult a qualified financial adviser before making investment decisions. Scores generated by the V56 momentum engine based on Jegadeesh & Titman (1993) momentum research and Barroso & Santa-Clara (2015) volatility targeting.